🏛️ Verified NIH Record • Updated 2026-06-11
Haloperidol and Lorazepam in Controlling Symptoms of Persistent Agitated Delirium in Patients With Advanced Cancer Undergoing Palliative Care (NCT03743649)
Strategies for Persistent Agitated Delirium in Palliative Care
🔵 Active, Not Recruiting Phase2 / Phase3 💊 Investigational Drug / Biologic Sponsor: M.D. Anderson Cancer Center
🩺 Plain-English Summary (8th-Grade Level)
This phase II/IIII trial studies how well haloperidol and lorazepam work in controlling symptoms of persistent agitated delirium in patients with cancer that has spread to other places in the body undergoing palliative care. Haloperidol and lorazepam may help in controlling symptoms of agitated delirium in patients with cancer and may lessen any distress that their caregivers may be experiencing.
Who can join: Review the eligibility criteria below.
Location: M D Anderson Cancer Center — Houston, Texas
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (3 Sites)
- M D Anderson Cancer Center — Houston, Texas
- Virginia Commonwealth University/Massey Cancer Center — Richmond, Virginia
- Hosptial de Cancer de Barretos — Barretos, São Paulo
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Delirium
- Digital Rehabilitation Environment Augmenting Medical System — Gainesville, Florida
- Delirium and Neuropsychological Recovery Among Emergency General Surgery Survivors — Rockford, Illinois
- Intelligent Intensive Care Unit — Gainesville, Florida
- Benzodiazepine-free Cardiac Anesthesia for Reduction of Postoperative Delirium — St Louis, Missouri
- Dexmedetomidine to Reduce the Incidence of POCD After Open Cardiac Surgery — Toronto, Ontario
Explore by condition: All Delirium clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.